Semaglutide is a medication that has gained popularity in recent years for its effectiveness in promoting weight loss and managing type 2 diabetes. The medication is available in various forms, under different brand names. Here are the most common ones:
- Ozempic: This is the most well-known brand name for semaglutide. Ozempic is a once-weekly injectable medication that is FDA-approved for the treatment of type 2 diabetes as well as for weight management in adults with obesity.
- Rybelsus: This is another brand name for semaglutide, which is FDA-approved for the treatment of type 2 diabetes. Rybelsus is unique in that it is an oral medication that is taken once daily, making it a convenient option for people who do not like needles.
- Wegovy: This is a new brand name for semaglutide that was approved by the FDA in June 2021. It is the first and only FDA-approved weight management medication that is taken once weekly as an injection. Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
- Semglee: This is a brand name for semaglutide that is not used for weight loss or diabetes management. Instead, Semglee is a biosimilar to insulin glargine and is used to treat diabetes mellitus in adults and children.
- Rezola: This is a brand name for a combination medication that contains both semaglutide and insulin aspart. Rezola is indicated for the treatment of adults with type 2 diabetes mellitus who require both semaglutide and insulin.
It is important to note that while these brand names may differ, they all contain the same active ingredient, semaglutide. It is always important to talk to your doctor about which form of semaglutide is best for your specific needs and medical history.
In summary, semaglutide is marketed under various brand names such as Ozempic, Rybelsus, Wegovy, Semglee, and Rezola. Each brand name is used to treat different medical conditions, but all contain the same active ingredient, semaglutide. It is essential to consult with a healthcare provider before starting any new medication.
